Measurement of Lipogenic Flux in Kidney Using Deuterium Oxide (D2O)

Background: Diabetes is the leading cause of end stage kidney disease in the United States. Previous studies in our laboratory using stable isotope have shown that hyperglycemia leads to increased de novo lipogenesis (DNL) in kidney cells.Though lipogenic 13C-substrates detect DNL with high sensitivity, quantification is complicated. Here we show that the stable isotope Deuterium (2H) can be used both in vitro and in vivo to overcome these challenges. D2O treatment enables labeling of most biomolecules making it ideal for multiomic study. Administration of D2O to biological systems is simpleand safe for longer time periods. Methods: We developed a method using LC/ /MS to measure 2H labeling in target metabolites. Deuterium incorporation is measured as mass shifts in the spectra (m+2, m+3). The lipogenic flux is measured as the percentage of 2H labeling in palmitate, the primary product of FASn. Results: Time and dosimetry studies in HK-2 cells show that incubating cells in media with 25% D2O for 48 hours is optimum to study lipogenic flux. DNLactivity in human podocyte under normal (NG) and hyperglycemic (HG) conditions was examined by incubating cells in D2O media with 5.5 mM or 25 mM glucose for 48 hours. As we have shown in our previous studies using 13C isotope, cells grown under hyperglycemic conditions show an enhanced 2H labeling of palmitate suggesting increased lipogenic flux (Fig A). For in vivo lipogenic flux studies mice with pathological features of DN (BKS db/db) and control (db/+) were given D2O (20ul/g BW) IP at 0 hour and 24 hour then sacrificed at 48 hour. Total lipids were extracted from kidney cortex and 2H labeling was analyzed. Our results show higher 2H labeling in diabetic mice kidney cortex (m+3, m+4 and m+5) (Fig B) indicating increased lipogenic flux. Conclusion: These results show that 2H labeling with LC/MS can be used to study lipogenic flux in target tissues both in vivo and in vitro. Funding: Private Foundation SupportResults of in vitro and in vivo Deuterium labeling in kidney cells.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025md8h453z
Primary Topic
Renal and Vascular Pathologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Measurement of Lipogenic Flux in Kidney Using Deuterium Oxide (D2O)

Subramaniam Pennathur, Alethia J Dixon, Keith Saum, Manikanta Swamy Arnipalli et al.
Journal of the American Society of Nephrology
Renal and Vascular Pathologies
article

Measurement of Lipogenic Flux in Kidney Using Deuterium Oxide (D2O)

Subramaniam Pennathur, Alethia J Dixon, Keith Saum, Manikanta Swamy Arnipalli, Gary F. Gerlach, Pradeep Kayampilly, Nancy F. Roeser
article en

Abstract

Background: Diabetes is the leading cause of end stage kidney disease in the United States. Previous studies in our laboratory using stable isotope have shown that hyperglycemia leads to increased de novo lipogenesis (DNL) in kidney cells.Though lipogenic 13C-substrates detect DNL with high sensitivity, quantification is complicated. Here we show that the stable isotope Deuterium (2H) can be used both in vitro and in vivo to overcome these challenges. D2O treatment enables labeling of most biomolecules making it ideal for multiomic study. Administration of D2O to biological systems is simpleand safe for longer time periods. Methods: We developed a method using LC/ /MS to measure 2H labeling in target metabolites. Deuterium incorporation is measured as mass shifts in the spectra (m+2, m+3). The lipogenic flux is measured as the percentage of 2H labeling in palmitate, the primary product of FASn. Results: Time and dosimetry studies in HK-2 cells show that incubating cells in media with 25% D2O for 48 hours is optimum to study lipogenic flux. DNLactivity in human podocyte under normal (NG) and hyperglycemic (HG) conditions was examined by incubating cells in D2O media with 5.5 mM or 25 mM glucose for 48 hours. As we have shown in our previous studies using 13C isotope, cells grown under hyperglycemic conditions show an enhanced 2H labeling of palmitate suggesting increased lipogenic flux (Fig A). For in vivo lipogenic flux studies mice with pathological features of DN (BKS db/db) and control (db/+) were given D2O (20ul/g BW) IP at 0 hour and 24 hour then sacrificed at 48 hour. Total lipids were extracted from kidney cortex and 2H labeling was analyzed. Our results show higher 2H labeling in diabetic mice kidney cortex (m+3, m+4 and m+5) (Fig B) indicating increased lipogenic flux. Conclusion: These results show that 2H labeling with LC/MS can be used to study lipogenic flux in target tissues both in vivo and in vitro. Funding: Private Foundation SupportResults of in vitro and in vivo Deuterium labeling in kidney cells.

Journal of the American Society of NephrologyVol. 36(10S)
University of Michigan (US), Michigan Medicine (US)
Openalex Percentile: Top 57%
Renal and Vascular Pathologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.